Presentation is loading. Please wait.

Presentation is loading. Please wait.

Treating HIV Infection:

Similar presentations


Presentation on theme: "Treating HIV Infection:"— Presentation transcript:

1 Treating HIV Infection:

2 HIV/AIDS Treatment A Dynamic Field

3 SINGLE Study Phase 3, Open-Label Extension Results, Weeks 96 to 144

4 Dolutegravir Clinical Trials Phase 3 Open-Label Extension Results, Weeks 96 to 144 (cont)

5 Pharmacoenhancers What's New?

6 COBI* vs RTV as a Pharmacoenhancer for TDF/FTC Efficacy Results at 144 Weeks

7 COBI vs RTV as a Pharmacoenhancer for TDF/FTC Safety Results at 144 Weeksa (cont)

8 COBI vs RTV as a Pharmacoenhancer for TDF/FTC Safety Results at 144 Weeks (cont)

9 Low Bone Mineral Density An Age- and ART-Related Comorbidity in People With HIV Infection

10 TAF: A Novel Tenofovir Prodrug Phase 2: DRV/cobi + TAF/FTC vs DRV/cobi + TDF/FTC: Efficacy

11 DRV/cobi + TAF/FTC vs DRV/cobi + TDF/FTC BMD Changes

12 DRV/r + RAL vs TDF/FTC Effect on BMD at 96 Weeks

13 Renal Markers More Favorable for TAF Compared With TDF Renal Function at 48 Weeks

14 Cabotegravir Injectable Long-acting Integrase Strand Transfer Inhibitors Dose-finding Study

15 Abbreviations

16 Abbreviations (cont)

17 References

18 References (cont)

19 References (cont)


Download ppt "Treating HIV Infection:"

Similar presentations


Ads by Google